SGLB Sigma Labs Inc

As previously reported, on October 14, 2022, Sigma Additive Solutions, Inc. (“we,” “our,” “us,” “Sigma,” or the “Company”) received notice from The Nasdaq Stock Market (“Nasdaq”) that, based on the previous 30 consecutive business days, our common stock no longer met the minimum $1 bid price per share requirement for continued listing. Therefore, in accordance with our Listing Rules (the “Rules”), we were provided 180 calendar days, or until April 12, 2023, to regain compliance. Although our common stock has not regained compliance with the minimum $1 bid price per share requirement, on April 13, 2023, Nasdaq notified us that the Nasdaq Staff has granted us an additional 180 calendar day period, or until October 9, 2023, to regain compliance based on our meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on The Nasdaq Capital Market with the exception of the bid price requirement, and our written notice of our intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary. According to Nasdaq’s notice, if at any time during this additional time period the closing bid price of our common stock is at least $1 per share for a minimum of 10 consecutive business days, the Staff will provide written confirmation of compliance and this matter will be closed.

If we choose to implement a reverse stock split, it must be completed no later than ten business days prior to October 9, 2023 to timely regain compliance. If it appears to Nasdaq that we will not be able to cure the deficiency, or if we are otherwise not eligible, Nasdaq will notify us that our common stock will be subject to delisting.